Back to Results

A randomized phase II study of anti-PD-1 and limited metastatic site radiation therapy versus anti-PD-1 alone for patients with microsatellite instability-high (MSI-H) and mismatch repair deficient (dMMR) metastatic solid tumors

Study category: Cancer

Is this Study for You?

Let's Get Started!




II - Research Studies that gather preliminary data on whether a drug works in people who have a certain condition/disease (that is, the drug's effectiveness). For example, participants receiving the drug may be compared to similar participants receiving a different treatment, usually an inactive substance (called a placebo) or a different drug. Safety continues to be evaluated, and short-term adverse events are studied.

Type of Study



Lone Tree Medical Center
University of Colorado Hospital

Principal Investigator
Christine Fisher,  MD, MPH

Christine Fisher, MD, MPH

Study ID

Protocol Number: 19-0556

More information available at NCT04001101

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers